GB9315306D0 - Methods - Google Patents

Methods

Info

Publication number
GB9315306D0
GB9315306D0 GB939315306A GB9315306A GB9315306D0 GB 9315306 D0 GB9315306 D0 GB 9315306D0 GB 939315306 A GB939315306 A GB 939315306A GB 9315306 A GB9315306 A GB 9315306A GB 9315306 D0 GB9315306 D0 GB 9315306D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939315306A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB939315306A priority Critical patent/GB9315306D0/en
Publication of GB9315306D0 publication Critical patent/GB9315306D0/en
Priority to NZ269990A priority patent/NZ269990A/xx
Priority to AU73708/94A priority patent/AU7370894A/en
Priority to PCT/US1994/008275 priority patent/WO1995003041A1/fr
Priority to CA002167841A priority patent/CA2167841A1/fr
Priority to ZA945416A priority patent/ZA945416B/xx
Priority to CN94193372A priority patent/CN1130870A/zh
Priority to EP94922684A priority patent/EP0713391A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB939315306A 1993-07-23 1993-07-23 Methods Pending GB9315306D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB939315306A GB9315306D0 (en) 1993-07-23 1993-07-23 Methods
NZ269990A NZ269990A (en) 1993-07-23 1994-07-22 Inhibiting hiv viruses; use of azaspirane compounds in preparation of medicaments
AU73708/94A AU7370894A (en) 1993-07-23 1994-07-22 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes
PCT/US1994/008275 WO1995003041A1 (fr) 1993-07-23 1994-07-22 Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues
CA002167841A CA2167841A1 (fr) 1993-07-23 1994-07-22 Methode d'inhibition de la production de virus d'immunodeficience humaine a l'aide de derives de substitution d'azaspiranes
ZA945416A ZA945416B (en) 1993-07-23 1994-07-22 Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
CN94193372A CN1130870A (zh) 1993-07-23 1994-07-22 用取代的氮杂螺环烃类化合物抑制人免疫缺陷病毒产生的方法
EP94922684A EP0713391A4 (fr) 1993-07-23 1994-07-22 Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315306A GB9315306D0 (en) 1993-07-23 1993-07-23 Methods

Publications (1)

Publication Number Publication Date
GB9315306D0 true GB9315306D0 (en) 1993-09-08

Family

ID=10739328

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939315306A Pending GB9315306D0 (en) 1993-07-23 1993-07-23 Methods

Country Status (8)

Country Link
EP (1) EP0713391A4 (fr)
CN (1) CN1130870A (fr)
AU (1) AU7370894A (fr)
CA (1) CA2167841A1 (fr)
GB (1) GB9315306D0 (fr)
NZ (1) NZ269990A (fr)
WO (1) WO1995003041A1 (fr)
ZA (1) ZA945416B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
HUP0003908A3 (en) * 1996-05-17 2001-04-28 Anormed Inc Langley Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315271D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
ZA945416B (en) 1995-05-10
NZ269990A (en) 1999-07-29
EP0713391A1 (fr) 1996-05-29
AU7370894A (en) 1995-02-20
CA2167841A1 (fr) 1995-02-02
EP0713391A4 (fr) 1998-09-09
WO1995003041A1 (fr) 1995-02-02
CN1130870A (zh) 1996-09-11

Similar Documents

Publication Publication Date Title
GB9419218D0 (en) Methods
DE69433664D1 (en) Foetal-sensor
DE69400639D1 (en) Rehydratationsgetraenk
DE69426415D1 (en) Intrapulmonares hormonabgabesystem
DE69421914D1 (en) Ekg-sensor
DE69401926D1 (en) Hydroxamsäurederivate
DE69406448D1 (en) Luftreinigungsgerät
DE69405713D1 (en) Carbonylierungsverfahren
DE69412242D1 (en) Orthopädisches gussmaterial
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
DE69423875D1 (en) Hydrodealkylierungsverfahren
DE59409705D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
DE59408644D1 (en) Jacquardmaschine
DE69429512D1 (en) Thermoresistente alpha-1-antitrypsinmütante
GB2274735B (en) Membraphone
DE69408437D1 (en) Oxychlorierungsverfahren
EP0730584A4 (fr) 3-acylaminobenzodiazepines
DE59408733D1 (en) Metallhalogenidentladungslampe
DE59410065D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9315306D0 (en) Methods
GB2274048B (en) Headcollars
DE69425743D1 (en) Faserreaktive anthrachinon-farbstoffe
DE69410761D1 (en) Polyacetalharzzusammensetzung
DE69412128D1 (en) Kühlcontainer
DE69407946D1 (en) Oxychlorierungskatalysator